Govt Panel To Help Boost Drug Manufacture, Pharma Funding

NEW DELHI : Aiming to boost local manufacture of essential medicines and attract investments in the pharma sector, the government is set to draw up a plan to build a drug regulatory system which is in line with the best globally and facilitates ease of doing business.

The move comes in the wake of rising demand for medicines during the Covid-19 pandemic worldwide amid supply shortages of some drugs, medical devices and other pharmaceutical products.

The government has now formed an expert committee under the department of pharma to identify bottlenecks and suggest measures that can help attract investments so that the drug manufacturing sector can ramp up capacities, add technology and also reduce dependence on imports for even raw material in the form of active pharmaceutical ingredient (API) and bulk drugs.

The committee has been asked to submit a preliminary report with action plan by end of this week, a source said.

The committee will examine the number and type of approvals and compliances needed in the sector by investors for setting up operations and compare them with the world. It has also been asked to identify common hurdles and bottlenecks.

Related Posts

  • Pharma
  • July 11, 2025
  • 91 views
India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

July:  India’s Glenmark Pharmaceuticals (GLEN.NS), opens new tab said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie (ABBV.N), opens new tab have signed an exclusive licensing agreement…

  • Pharma
  • July 10, 2025
  • 146 views
Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

India’s Glenmark Pharma unit, AbbVie sign exclusive licensing pact

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Novartis wins approval for first malaria drug for newborns and babies

Novartis wins approval for first malaria drug for newborns and babies